RTTNews | Nov 12, 2021 07:03AM EST

07:03 Friday, November 12, 2021 (RTTNews) - Compugen Presents Preliminary Results From Phase 1/2 Dose Escalation Study Of COM701 With Opdivo And BMS-986207

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved